Key dates

 

1952 Company’s foundation by Mr. Claude Dufour in the western suburb of Paris (Boulogne under the name of «Laboratoires du Bois de Boulogne» and renamed the company SEAC.

 

1962 SEAC moves its industrial operations to the current location near Lille in the North of France, known as Minakem Beuvry-la-Forêt since 2005.

 

1974 Construction of the Louvain-la-Neuve Site for Vinca Alkaloids production, owned by Ajinomoto Omnichem since 1989.

 

1995 Construction of the new Plant in Dunkirk by AstraZeneca.

 

1998 Louvain-la-Neuve site major upgrade to allow handling of highly actives and cytotoxic products under strict containment (OEB class 5).

 

2005 Minakem takes over the SEAC operations, with all assets related to custom synthesis, including R&D laboratories, pilot plant and manufacturing resources in Beuvry-la-Forêt.

 

2009 Minakem expands it reactor capacity by 150m3 by acquiring the Dunkirk plant. It also adds steroid manufacturing, micronization and injectable capabilities to its growing technology base.

 

2015 Last acquisition to date, Minakem takes over Ajinomoto’s business and site in order to expand Minakem’s expertise and offer range into high-potency active pharmaceutical ingredients (HAPIs) and develop pharma productions that require high-level containment facilities.

Minakem is a member of the Minafin Group founded in 2005 by Frédéric Gauchet.

Visit Minafin’s web site: www.minafin.com